Anhui Huaheng Biotechnology Co., Ltd.

SHSE:688639 Rapport sur les actions

Capitalisation boursière : CN¥8.3b

Anhui Huaheng Biotechnology Bilan de santé

Santé financière contrôle des critères 2/6

Anhui Huaheng Biotechnology possède un total de capitaux propres de CN¥1.9B et une dette totale de CN¥2.0B, ce qui porte son ratio d'endettement à 110.1%. Son actif total et son passif total sont CN¥4.7B et de CN¥2.8B. L'EBIT de Anhui Huaheng Biotechnology est CN¥328.7M ce qui fait que son ratio de couverture des intérêts 11.8. Elle dispose de liquidités et de placements à court terme de CN¥445.3M.

Informations clés

110.1%

Ratio d'endettement

CN¥2.04b

Dette

Ratio de couverture des intérêts11.8x
Argent liquideCN¥445.31m
Fonds propresCN¥1.86b
Total du passifCN¥2.85b
Total des actifsCN¥4.70b

Mises à jour récentes de la santé financière

Recent updates

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Oct 21
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Soars 35% But It's A Story Of Risk Vs Reward

Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Oct 14
Here's Why We Think Anhui Huaheng Biotechnology (SHSE:688639) Is Well Worth Watching

Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Sep 05
Slammed 29% Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Screens Well Here But There Might Be A Catch

Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Sep 03
Anhui Huaheng Biotechnology's (SHSE:688639) Profits Appear To Have Quality Issues

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Sep 02
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Analysts Just Cut Their EPS Forecasts Substantially

Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Aug 20
Many Would Be Envious Of Anhui Huaheng Biotechnology's (SHSE:688639) Excellent Returns On Capital

Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jul 22
Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Jul 12
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Intrinsic Value Is Potentially 43% Above Its Share Price

Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Jun 21
Is Anhui Huaheng Biotechnology (SHSE:688639) Using Too Much Debt?

Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

Jun 05
Take Care Before Jumping Onto Anhui Huaheng Biotechnology Co., Ltd. (SHSE:688639) Even Though It's 27% Cheaper

We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

May 12
We Ran A Stock Scan For Earnings Growth And Anhui Huaheng Biotechnology (SHSE:688639) Passed With Ease

Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Apr 23
Earnings Report: Anhui Huaheng Biotechnology Co., Ltd. Missed Revenue Estimates By 37%

Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Mar 18
Anhui Huaheng Biotechnology Co., Ltd.'s (SHSE:688639) Business Is Trailing The Market But Its Shares Aren't

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de 688639 ( CN¥1.2B ) ne couvrent pas ses passifs à court terme ( CN¥2.1B ).

Passif à long terme: Les actifs à court terme de 688639 ( CN¥1.2B ) dépassent ses passifs à long terme ( CN¥796.8M ).


Historique et analyse du ratio d'endettement

Niveau d'endettement: Le ratio dette nette/capitaux propres de 688639 ( 86.1% ) est considéré comme élevé.

Réduire la dette: Le ratio d'endettement de 688639 est passé de 20.9% à 110.1% au cours des 5 dernières années.

Couverture de la dette: La dette de 688639 n'est pas bien couverte par le flux de trésorerie opérationnel ( 1.8% ).

Couverture des intérêts: Les paiements d'intérêts de 688639 sur sa dette sont bien couverts par l'EBIT ( 11.8 x couverture).


Bilan


Découvrir des entreprises saines